Skip to content

Feasibility Study of the HAP3 Family App and Dashboard

Healthy Adaptation to Pregnancy, Postpartum and Parenthood (HAP3)Feasibility Study of the HAP3 Family App and Dashboard Targeting Health Behaviours for Weight and Mental Health in Women, Partners, and Offspring During Pregnancy and Postpartum - Feasibility Study of the HAP3 Family App and Dashboard

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON61381
Enrollment
192
Registered
2025-12-15
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight, mental health, child development, perinatal period, parenting Weight, mental health, child development, during and after pregnancy period, being a parent

Interventions

Intervention: The HAP3 Family App, delivered via the existing m-path platform, contains evidence-based modules on pregnancy and postpartum care, mental health, physical activity, sleep, nutrition, wei
usability is measured using the mHealth App Usability Questionnaire (MAUQ) and short interviews. Motivation and behavioural change are measured for weight management using Self-reported Weight and Per

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: For the pilot study: To be eligible to participate in this study, a pregnant person must (1) be aged 18 years or older, (2) be currently pregnant, (3) have sufficient proficiency in Dutch, German, or English, (4) reside in Belgium, the Netherlands, or Germany, (5) be capable of giving consent.A postpartum person must (1) be aged 18 years or older, (2) be within 6 months after birth, (3) have sufficient proficiency in Dutch, German, or English, (4) reside in Belgium, the Netherlands, or Germany, (5) be capable of giving consent.Partners of a pregnant or postpartum person must (1) be aged 18 years or older, (2) have sufficient proficiency in Dutch, German, or English, (3) reside in Belgium, the Netherlands, or Germany, (5) be capable of giving consent. For the RCT: To be eligible to participate in this study, a person must meet all of the following criteria. The person must (1) be aged 18 years or older, (2) be currently pregnant*, (3) have sufficient proficiency in Dutch, German, or English, (4) reside in Belgium, the Netherlands, or Germany, (5) be capable of giving consent.Partners of the pregnant person* must (1) be aged 18 years or older, (2) have sufficient proficiency in Dutch, German, or English, (3) reside in Belgium, the Netherlands, or Germany, (5) be capable of giving consent.* As this is a feasibility trial, our primary aim is to recruit the majority of pregnant people before 16 weeks of pregnancy to capture early developmental windows. Nevertheless, to ensure feasibility and to reflect real-world recruitment conditions, we will include women (and their partners) at any stage of pregnancy.

Exclusion criteria

Exclusion criteria: For the pilot study: A potential participant, either a pregnant person, a postpartum person or partners, who meets any of the following criteria will be excluded from participation in this study: (1) current suicidal ideation, (2) severe diagnosed mental health disorders (e.g., bipolar disorder, schizophrenia, borderline personality disorder), (3) Severely debilitating physical health conditions (e.g., advanced cardiovascular or respiratory disease or active cancer or severe hyperemesis gravidarum) that substantially affect daily functioning, (4) history of or planned bariatric surgery during the time of the study, (5) no signed informed consent, or (6) current or planned enrollment in another clinical trial. For the RCT: A potential participant, either a pregnant person or partner, who meets any of the following criteria will be excluded from participation in this study: (1) current suicidal ideation, (2) severe mental health disorders (e.g., bipolar disorder, schizophrenia, borderline personality disorder,) (3) Severely debilitating physical health conditions (e.g., advanced cardiovascular or respiratory disease or active cancer or severe hyperemesis gravidarum) that substantially affect daily functioning, (4) history of or planned bariatric surgery during the time of the study, (5) no signed informed consent, or (6) current or planned enrollment in another clinical trial.

Design outcomes

Primary

MeasureTime frame
Study parameters: Primary feasibility parameters include recruitment and retention rates, protocol adherence, app engagement, data completeness, and participant-reported acceptance and usability. 

Secondary

MeasureTime frame
Study parameters: Secondary parameters include maternal and partner mental health, eating behaviour, body composition including weight, and child development, measured using validated questionnaires, anthropometric measurements, and EMA questions about mood, nutrition, sleep, and stress.

Countries

Belgium, Germany, Netherlands

Contacts

Public ContactM Oosterman

Vrije Universiteit

m.oosterman@vu.nl0205988979

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026